Monday’s announcement by the Food and Drug Administration (FDA) of accelerated approval for Exondys 51 (eteplirsen) injection, the first…
Kara Elam
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Kara Elam
Integrin Protein May Lead to Potential Target for Muscular Dystrophy Therapies, Researchers Say
A protein known as integrin may play a key role in muscle tissue growth after injury or disease, a finding…
Researchers at Japan’s Kobe University Graduate School of Medicine have successfully decoded a sugar molecule, providing an important step toward understanding a…
Researchers from the University of Pittsburgh recently released key findings from a study which may hold important implications for novel…
A group of international researchers has published a review of clinical trials for a drug that shows significant potential as…
The Wnt signaling pathway might one day be a promising target for Duchenne muscular dystrophy (DMD) cognitive therapy, with potential clinical implications,…
Researchers have treated a zebrafish animal model with a tyrosine kinase inhibitor to study its effect on fish musculature and strength in an…
This week, a group of interdisciplinary researchers from universities throughout Italy released study findings with potentially important clinical implications for…
Catabasis Pharmaceuticals Begins MoveDMD Trial For The Treatment of Duchenne Muscular Dystrophy
Massachusetts based Catabasis Pharmaceuticals, a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on…
This week researchers from the Institute for Neurodegenerative Disease, Massachusetts General Hospital (MGH), Harvard Medical School, released results from a…